The lack of typical symptoms at early stage, biomarkers with indicative significance for early screening and markers predicting the efficacy of various treatment strategies, and early cancer metastasis have significantly contributed to the dismal prognosis of these patients.
← all excerpts
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
1
—
—